Provenzano Claudia, Zamboni Michela, Veneziano Liana, Mantuano Elide, Garavaglia Barbara, Zorzi Giovanna, Pagonabarraga Javier, Giunti Paola, Civitareale Donato
Institute of Cell Biology and Neurobiology, National Council of Research, 00015 Monterotondo, Italy.
Institute of Translational Pharmacology, National Council of Research, 00100 Rome, Italy.
J Neurol Sci. 2016 Jan 15;360:78-83. doi: 10.1016/j.jns.2015.11.050. Epub 2015 Nov 27.
The thyroid transcription factor 1 (TTF-1) is encoded, on chromosome 14q13, by the gene termed TITF-1/NKX2.1. Mutations in this gene have been associated with chorea, hypothyroidism, and lung disease, all included in the "brain-thyroid-lung syndrome." We here describe two cases of novel missense mutations [NM_003317.3:c.516G>T and c.623G>C resulting in p.(Gln172His) and p.(Trp208Ser), respectively] in TITF-1/NKX2-1 in non-consanguineous patients. We provide a functional study of the role of the two mutations on the TTF-1 ability to bind DNA and to trans-activate both thyroid and lung specific gene promoters. Our results confirm the difficulty to correlate the TTF-1 activity with the clinical phenotype of affected patients and highlight the need to increase the limited knowledge we have on the activity of TTF-1 in neuronal cells.
甲状腺转录因子1(TTF-1)由位于14q13染色体上的名为TITF-1/NKX2.1的基因编码。该基因的突变与舞蹈症、甲状腺功能减退和肺部疾病有关,这些都包含在“脑-甲状腺-肺综合征”中。我们在此描述了两例非近亲患者中TITF-1/NKX2-1基因的新型错义突变[NM_003317.3:c.516G>T和c.623G>C,分别导致p.(Gln172His)和p.(Trp208Ser)]。我们对这两种突变在TTF-1结合DNA以及反式激活甲状腺和肺特异性基因启动子能力方面的作用进行了功能研究。我们的结果证实了将TTF-1活性与受影响患者的临床表型相关联存在困难,并强调需要增加我们对TTF-1在神经元细胞中活性的有限认识。